Informações:
Falhas:
ID
30046
Descrição
Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366); ODM derived from: https://clinicaltrials.gov/show/NCT01368185
Link
https://clinicaltrials.gov/show/NCT01368185
Palavras-chave
Versões (1)
- 05/05/2018 05/05/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
5 de maio de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hypertension NCT01368185
Eligibility Hypertension NCT01368185
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01368185
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
participant was >20 years and <75 years of age on the index date (i.e., the date of initiating mk-0954a therapy)
boolean
C0001779 (UMLS CUI [1])
Hypertensive disease | Losartan Potassium
Item
diagnosed with hypertension and had received mk-0954a 50/12.5 mg for at least 3 months
boolean
C0020538 (UMLS CUI [1])
C0700492 (UMLS CUI [2])
C0700492 (UMLS CUI [2])
Serum uric acid measurement Quantity | Status post Use of Losartan Potassium
Item
had at least one serum uric acid measurements at baseline and one at 3 months after using mk-0954a 50/12.5 mg
boolean
C0455272 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700492 (UMLS CUI [2,3])
C1265611 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700492 (UMLS CUI [2,3])
Records Documented
Item
had the following records documented in the chart during the data collection period:
boolean
C0034869 (UMLS CUI [1,1])
C1301725 (UMLS CUI [1,2])
C1301725 (UMLS CUI [1,2])
Medical History | Comorbidity
Item
medical history and co-morbidities (if available)
boolean
C0262926 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
C0009488 (UMLS CUI [2])
Sitting blood pressure | Serum uric acid measurement | Lipid profile test
Item
sitting blood pressure, serum uric acid, lipid profile test results before and after using mk-0954a 50/12.5 mg
boolean
C0580946 (UMLS CUI [1])
C0455272 (UMLS CUI [2])
C0850354 (UMLS CUI [3])
C0455272 (UMLS CUI [2])
C0850354 (UMLS CUI [3])
Electrolytes measurement, serum | Creatinine measurement, serum | Sugar pre-meal
Item
serum electrolytes, serum creatinine, and pre-meal sugar (if available)
boolean
C0587355 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0007004 (UMLS CUI [3,1])
C1546096 (UMLS CUI [3,2])
C0201976 (UMLS CUI [2])
C0007004 (UMLS CUI [3,1])
C1546096 (UMLS CUI [3,2])
Prescription document Antihypertensive therapy
Item
prescription information of all antihypertensive regimens
boolean
C1521941 (UMLS CUI [1,1])
C0585941 (UMLS CUI [1,2])
C0585941 (UMLS CUI [1,2])
Diuretics | Angiotensin II receptor antagonist
Item
had been treated with diuretic or angiotensin-receptor blockers (arbs) 2 weeks before initiated treatment with mk-0954a 50/12.5 mg
boolean
C0012798 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0521942 (UMLS CUI [2])
Creatinine measurement, serum
Item
serum creatinine >2 mg/dl
boolean
C0201976 (UMLS CUI [1])